Jiangsu Lanfeng Bio-chemical Co Ltd (SHE:002513) — Market Cap & Net Worth
Market Cap & Net Worth: Jiangsu Lanfeng Bio-chemical Co Ltd (002513)
Jiangsu Lanfeng Bio-chemical Co Ltd (SHE:002513) has a market capitalization of $267.66 Million (CN¥1.83 Billion) as of August 5, 2026. Listed on the SHE stock exchange, this China-based company holds position #15318 globally and #4519 in its home market, demonstrating a 10.43% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Jiangsu Lanfeng Bio-chemical Co Ltd's stock price CN¥4.87 by its total outstanding shares 375593978 (375.59 Million). See 002513 capex to operating cash flow ratio to understand how much of operating cash flow is reinvested back into capital assets.
Jiangsu Lanfeng Bio-chemical Co Ltd Market Cap History: 2015 to 2026
Jiangsu Lanfeng Bio-chemical Co Ltd's market capitalization history from 2015 to 2026. Data shows change from $1.07 Billion to $267.66 Million (-9.56% CAGR).
Jiangsu Lanfeng Bio-chemical Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Jiangsu Lanfeng Bio-chemical Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.16x
Jiangsu Lanfeng Bio-chemical Co Ltd's market cap is 0.16 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $890.13 Million | $1.46 Billion | $107.28 Million | 0.61x | 8.30x |
| 2017 | $551.26 Million | $1.85 Billion | $35.45 Million | 0.30x | 15.55x |
| 2018 | $357.25 Million | $1.48 Billion | -$874.95 Million | 0.24x | N/A |
| 2019 | $390.77 Million | $1.50 Billion | -$516.56 Million | 0.26x | N/A |
| 2020 | $217.65 Million | $1.34 Billion | $14.82 Million | 0.16x | 14.68x |
| 2021 | $274.26 Million | $1.44 Billion | -$491.19 Million | 0.19x | N/A |
| 2022 | $284.15 Million | $1.45 Billion | -$320.69 Million | 0.20x | N/A |
| 2023 | $380.33 Million | $1.74 Billion | -$332.26 Million | 0.22x | N/A |
| 2024 | $246.23 Million | $1.79 Billion | -$252.50 Million | 0.14x | N/A |
| 2025 | $369.34 Million | $2.34 Billion | -$190.53 Million | 0.16x | N/A |
Competitor Companies of 002513 by Market Capitalization
Companies near Jiangsu Lanfeng Bio-chemical Co Ltd in the global market cap rankings as of August 5, 2026.
Key companies related to Jiangsu Lanfeng Bio-chemical Co Ltd by market ranking:
- Corteva Inc (NYSE:CTVA): Ranked #522 globally with a market cap of $51.14 Billion USD.
- Nutrien Ltd (TO:NTR): Ranked #800 globally with a market cap of $33.60 Billion USD ( CA$46.45 Billion CAD).
- Qinghai Salt Lake Industry Co.Ltd (SHE:000792): Ranked #1201 globally with a market cap of $21.22 Billion USD ( CN¥144.99 Billion CNY).
- CF Industries Holdings Inc (NYSE:CF): Ranked #1479 globally with a market cap of $16.81 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #522 | Corteva Inc | NYSE:CTVA | $51.14 Billion | $76.04 |
| #800 | Nutrien Ltd | TO:NTR | $33.60 Billion | CA$96.76 |
| #1201 | Qinghai Salt Lake Industry Co.Ltd | SHE:000792 | $21.22 Billion | CN¥27.40 |
| #1479 | CF Industries Holdings Inc | NYSE:CF | $16.81 Billion | $118.30 |
Jiangsu Lanfeng Bio-chemical Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Jiangsu Lanfeng Bio-chemical Co Ltd's market cap moved from $1.07 Billion to $ 267.66 Million, with a yearly change of -9.56%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥267.66 Million | -27.53% |
| 2025 | CN¥369.34 Million | +50.00% |
| 2024 | CN¥246.23 Million | -35.26% |
| 2023 | CN¥380.33 Million | +33.85% |
| 2022 | CN¥284.15 Million | +3.61% |
| 2021 | CN¥274.26 Million | +26.01% |
| 2020 | CN¥217.65 Million | -44.30% |
| 2019 | CN¥390.77 Million | +9.38% |
| 2018 | CN¥357.25 Million | -35.19% |
| 2017 | CN¥551.26 Million | -38.07% |
| 2016 | CN¥890.13 Million | -16.68% |
| 2015 | CN¥1.07 Billion | -- |
End of Day Market Cap According to Different Sources
On Aug 4th, 2026 the market cap of Jiangsu Lanfeng Bio-chemical Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $267.66 Million USD |
| MoneyControl | $267.66 Million USD |
| MarketWatch | $267.66 Million USD |
| marketcap.company | $267.66 Million USD |
| Reuters | $267.66 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Jiangsu Lanfeng Bio-chemical Co Ltd
Jiangsu Lanfeng Bio-chemical Co.,Ltd researches, develops, produces, and sells pesticides, fungicides, insecticides, herbicides, and fine chemical intermediates in China and internationally. It offers carbendazim, thiophanate-methyl, cycloazinone, carbosulfan butyl, sulfuric acid, and surfactant. Jiangsu Lanfeng Bio-chemical Co.,Ltd was founded in 1976 and is based in Xinyi, China.